(Q33938276)

30 July 2017

title

Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness (English)

1 reference

30 July 2017

1 reference

1 reference

Susannah L Rose

1

1 reference

30 July 2017

publication date

1 January 2013

1 reference

Journal of Law, Medicine, and Ethics

30 July 2017

published in

1 reference

30 July 2017

volume

41

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

680-687

1 reference

Understanding pharmaceutical research manipulation in the context of accounting manipulation

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Industry sponsorship and research outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Patient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

The impact of disclosing financial ties in research and clinical care: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Effects of disclosing financial interests on participation in medical research: a randomized vignette trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Everyone's a little bit biased (even physicians).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Should patient groups accept money from drug companies? No.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Should patient groups accept money from drug companies? Yes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

The patient as a policy factor: a historical case study of the consumer/survivor movement in mental health

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Trust and distrust in organizations: emerging perspectives, enduring questions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Relationships between the pharmaceutical industry and patients' organisations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

A national survey of policies on disclosure of conflicts of interest in biomedical research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Physicians and the pharmaceutical industry: is a gift ever just a gift?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Understanding Financial Conflicts of Interest

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJLME.12078

Drug companies told that sponsoring patients' groups might help win approval for their products

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJLME.12078

Drug firms, the codification of diagnostic categories, and bias in clinical guidelines

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Curbing misconduct in the pharmaceutical industry: insights from behavioral ethics and the behavioral approach to law.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

The unintended consequences of conflict of interest disclosure.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Health advocacy organizations and evidence-based medicine.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Public disclosure of conflicts of interest: moving the policy debate forward.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Effect of exposure to small pharmaceutical promotional items on treatment preferences.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Health consumer and patients' organizations in Europe: towards a comparative analysis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

A trial of disclosing physicians' financial incentives to patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Pharmaceuticals and the consumer movement: the ambivalences of 'patient power'.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Industry funding of patients' support groups: declaration of competing interests is rare in Italian breast cancer associations

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

How disclosing HMO physician incentives affects trust.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Can public trust in nonprofits and governments be restored?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

The functions and limitations of trust in the provision of medical care.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Patients' Views on Financial Conflicts of Interest in Cancer Research Trials

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4107906

Sunshine laws and the pharmaceutical industry

29 October 2018

1 reference

12 December 2020

Whose deaths matter? Mortality, advocacy, and attention to disease in the mass media

1 reference

12 December 2020

The increasingly complex world of cancer patient advocacy organizations

1 reference

12 December 2020

Source of funding and outcome of clinical trials

1 reference

12 December 2020

Conflict of interest in the debate over calcium-channel antagonists

1 reference

12 December 2020

Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest

1 reference

12 December 2020

Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research

1 reference

12 December 2020

Identifiers

DOI

10.1111/JLME.12078

1 reference

30 July 2017

1 reference

30 July 2017

1 reference